Category of the cased countries.

Given that the pharmaceutical market has experienced severe market failures, it is necessary that we regulate pharmaceutical prices for many countries. Toward ensuring that pharmaceutical price regulation is efficient, this study investigated the antecedents that lead to an unreasonable pharmaceutical price. Based on 33 case-study countries, this study utilized QCA to analyze the conditional configuration of unreasonable pharmaceutical prices from the perspective of medical service provision. The results showed that the causes of unreasonable pharmaceutical prices are configured by medical service provision, especially cost compensation systems and payment mechanism. This study’s conclusions contribute to the research on pharmaceutical price regulation and the institution of medical service provision.鉴于医药市场已出现严重的市场失灵，多国均需对药品价格开展监管。为保障药品价格监管的科学性与有效性，本研究聚焦引发药品价格不合理现象的前因因素。本研究以33个案例国家为研究样本，采用定性比较分析（Qualitative Comparative Analysis，QCA）方法，从医疗服务供给视角解析药品价格不合理现象的条件组态。研究结果表明，药品价格不合理的成因组态由医疗服务供给相关要素构成，其中尤以成本补偿制度与支付机制为关键维度。本研究结论可为药品价格监管研究及医疗服务供给制度建设提供有益的学术参考。